Brainstorm Cell Therapeutics Files 8-K
Ticker: BCLI · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1137883
| Field | Detail |
|---|---|
| Company | Brainstorm Cell Therapeutics Inc. (BCLI) |
| Form Type | 8-K |
| Filed Date | Jun 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, financials
Related Tickers: BCLI
TL;DR
Brainstorm Cell Therapeutics filed an 8-K on June 16, 2025, likely containing financial updates and other material events.
AI Summary
On June 16, 2025, Brainstorm Cell Therapeutics Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant occurrences. No specific monetary transactions or new events were detailed in the provided excerpt.
Why It Matters
This 8-K filing signals that Brainstorm Cell Therapeutics Inc. is providing updated information to the SEC, which could include material events or financial disclosures relevant to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate disclosure of negative events, thus carrying a low immediate risk.
Key Players & Entities
- Brainstorm Cell Therapeutics Inc. (company) — Registrant
- June 16, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-36641 (filing_id) — SEC File Number
- 20-7273918 (ein) — IRS Employer Identification No.
FAQ
What specific "Other Events" are being reported by Brainstorm Cell Therapeutics Inc. in this 8-K filing?
The provided excerpt of the 8-K filing does not detail the specific "Other Events" being reported, only that this item is included.
What is the significance of the "Financial Statements and Exhibits" being filed?
Filing "Financial Statements and Exhibits" typically means the company is providing updated financial information or supporting documents as required by the SEC.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 16, 2025.
What is Brainstorm Cell Therapeutics Inc.'s state of incorporation?
Brainstorm Cell Therapeutics Inc. is incorporated in Delaware.
What is the SEC file number for Brainstorm Cell Therapeutics Inc.?
The SEC file number for Brainstorm Cell Therapeutics Inc. is 001-36641.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding BRAINSTORM CELL THERAPEUTICS INC. (BCLI).